Probiotics are bacteria that are beneficial to the human body and are an important part of the intestinal flora. In the fast-paced modern life, gut health is becoming more and more important. The relationship between probiotics and intestinal balance is like a double-edged sword, which can not only protect our health, but also can lead to various diseases. It is worth noting that while the probiotics industry is developing rapidly, it has also exposed the hidden dangers of "lack of science" such as exaggerated publicity and vague ingredient information. In order to provide consumers with more quality assured products and call on the whole industry to pay attention to the quality of probiotics, H&H Group China, together with top experts and scholars from China and France, jointly launched a "Sino-French Children's Probiotics Standardization Traceability and Evidence-Based Journey", discussed the standardized development path of children's probiotics, and traced the secrets of the birth of high-quality children's probiotics through "scientific evidence-based", leading the global probiotics market to a new era of standardization and high quality.
H&H Group China joined hands with France experts to start the journey of probiotic traceability
As microorganisms that are beneficial to human health, the scientific and effective efficacy of probiotics is crucial. The increasing demand for "scientific evidence-based" probiotic products for children in global families has become the key to integrating the professional strength of industry and academia to promote the upgrading of the global probiotic industry. To this end, the "Sino-French Children's Probiotics Standardization Seminar" jointly organized by Biostime and France Lallemand Group, China Nutrition and Health Food Association and Jingdong Health is of great significance, and Chinese and French scholars and industry leaders jointly discuss the standardization of children's probiotics, which will further strengthen the global authoritative exchange and application of results.
As a world-renowned probiotic company focusing on probiotics for 90 years, behind the rich scientific research content of Raman France is the outstanding ability in strain research, product development and quality control. This time, the guests visited the "France Lallemand Probiotics Standard Laboratory", and experienced the scientific research certification experiment of France Raman around [Bifidobacterium infantis R0033], further unveiling the mystery of the production of global high-standard children's probiotics that are more suitable for babies.
In fact, as early as 1999, Biostime reached a strategic partnership with France Lallemand Group, and took the lead in developing and launching the Biostime probiotics, which are now sold all over the world and recognized by thousands of families. Synbiotic probiotics select multi-strain intestinal native bacteria combination, the strain combination has been clinically verified for infants and young children in France, Canada, China, Spain, Serbia and other countries, and the product has obtained more than 20 product clinical verifications, confirming that the product is indeed effective in gastrointestinal conditioning and improving immunity. In order to further activate the market, Biostime continues to break through product agents and usage scenarios, and subdivides dosage forms such as drops and bacterial powders to meet the needs of healthy development at all stages and help the industry grow and expand.
H&H Group China and France Laman reached a strategic cooperation
The "Sino-French Children's Probiotics Standardization Traceability" is not only the epitome of the deepening cooperation between Biostime and France Lallemand Group, but also an important measure to show the scientific, safe and transparent production process to consumers and promote the standardization and scientific development of the global children's probiotics market.
H&H Group China Synbiotic Probiotics maintains a leading position
In recent years, the public has paid more and more attention to intestinal health, and the demand for probiotic products has become more and more high. Experts and scholars, industry leaders and business representatives from China and France conducted in-depth exchanges on topics such as the scientific and internationalization of children's probiotics, bringing a scientific thinking "collision" for the high-quality and sustainable development of the industry. It is expected that Biostime will continue to uphold the principles of scientific evidence-based and quality first, work with global partners to promote the healthy development of the children's probiotics market, and lead the industry to a more standardized and prosperous future.